VR Scientific: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VR Scientific
Largest movements
- Cash -€18,550
down €18,550 (-62.3%), from €29,791 to €11,242
mainly Contributions, distributions and other (-€44,993) and Receivables within one year (-€13,899)
- Receivables within one year +€13,899
up €13,899 (+313.6%), from €4,432 to €18,330
of which Trade receivables: +€13,334
- Deferred charges and accrued income -€9,314
no longer reported in 2025 (was €9,314)
- Tangible fixed assets -€553
down €553 (-14.9%), from €3,712 to €3,159
- Reserves -€26,707
down €26,707 (-89.0%), from €29,993 to €3,285
- Other debts +€12,598
up €12,598 (+1072.0%), from €1,175 to €13,774
- Gross operating margin -€4,561
down €4,561 (-15.1%), from €30,154 to €25,593
- Financial charges -€2,928
down €2,928 (-98.6%), from €2,969 to €41
- Taxes -€690
down €690 (-11.3%), from €6,122 to €5,431
- Other operating charges +€540
new in 2025: €540
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €47,248 | €32,731 | -€14,517 | -30.7% |
| Fixed assets | 21/28 | €3,712 | €3,159 | -€553 | -14.9% |
| Tangible fixed assets | 22/27 | €3,712 | €3,159 | -€553 | -14.9% |
| Plant, machinery and equipment | 23 | €3,712 | €3,159 | -€553 | -14.9% |
| Current assets | 29/58 | €43,536 | €29,572 | -€13,965 | -32.1% |
| Amounts receivable within one year | 40/41 | €4,432 | €18,330 | +€13,899 | +313.6% |
| Trade receivables | 40 | €4,427 | €17,762 | +€13,334 | +301.2% |
| Other amounts receivable | 41 | €4 | €569 | +€564 | +12681.1% |
| Cash at bank and in hand | 54/58 | €29,791 | €11,242 | -€18,550 | -62.3% |
| Deferred charges and accrued income | 490/1 | €9,314 | - | -€9,314 | |
| Total equity and liabilities | 10/49 | €47,248 | €32,731 | -€14,517 | -30.7% |
| Equity | 10/15 | €32,493 | €5,785 | -€26,707 | -82.2% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €29,993 | €3,285 | -€26,707 | -89.0% |
| Distributable reserves | 133 | €29,993 | €3,285 | -€26,707 | -89.0% |
| Amounts payable | 17/49 | €14,756 | €26,946 | +€12,190 | +82.6% |
| Amounts payable within one year | 42/48 | €14,756 | €26,946 | +€12,190 | +82.6% |
| Trade debts | 44 | €487 | €509 | +€21 | +4.4% |
| Suppliers | 440/4 | €487 | €509 | +€21 | +4.4% |
| Taxes, remuneration and social security | 45 | €13,093 | €12,663 | -€430 | -3.3% |
| Taxes | 450/3 | €13,093 | €12,663 | -€430 | -3.3% |
| Other amounts payable | 47/48 | €1,175 | €13,774 | +€12,598 | +1072.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,018 | €1,296 | +€278 | +27.3% |
| Other operating charges | 640/8 | - | €540 | +€540 | |
| Gross operating margin | 9900 | €30,154 | €25,593 | -€4,561 | -15.1% |
| Operating profit (loss) | 9901 | €29,137 | €23,757 | -€5,379 | -18.5% |
| Financial charges | 65/66B | €2,969 | €41 | -€2,928 | -98.6% |
| Recurring financial charges | 65 | €2,969 | €41 | -€2,928 | -98.6% |
| Profit (loss) for the period before taxes | 9903 | €26,168 | €23,717 | -€2,451 | -9.4% |
| Income taxes | 67/77 | €6,122 | €5,431 | -€690 | -11.3% |
| Profit (loss) for the period | 9904 | €20,047 | €18,285 | -€1,761 | -8.8% |
| Profit (loss) for the period to be appropriated | 9905 | €20,047 | €18,285 | -€1,761 | -8.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.